Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201

• Status: Terminated
• Trial end date: 2005-10-01

Summary

The purpose of this study is to determine the safety and antiviral activity of Clevudine, when retreated to patients previously treated with Clevudine

• Phase: Phase 2

Details

• Lead Sponsor: Bukwang Pharmaceutical
• Treatments: Clevudine